Therapy-related orbital myeloid sarcoma is very rare (1). A 61-year-old woman was admitted because of protrusion of the right eyeball (Picture 1). Computed tomography revealed a mass lesion in the right orbit that showed the uptake of 18F-fluorodeoxyglucose on positron emission tomography (Picture 2). A biopsy of the right orbit mass revealed proliferation of atypical cells that were positive for myeloperoxidase (Picture 3). A bone marrow examination showed neither an increase in blasts nor myelodysplasia. A diagnosis of myeloid sarcoma confined to the right orbit was made. She had a history of ovarian carcinoma treated with irinotecan and cisplatin 10 years earlier, so her disease was classified as therapy-related myeloid neoplasm (2). She received remission-induction chemotherapy for acute myeloid leukemia (idarubicin plus cytarabine) followed by a consolidation radiotherapy toward the right orbit. After the treatment, the protrusion of the right eyeball was markedly improved (Picture 4).
Picture 1.
Picture 2.
Picture 3.
Picture 4.
The authors state that they have no Conflict of Interest (COI).
References
- 1. Peker D, Parekh V, Paluri R, et al. Clinicopathological and molecular features of myeloid sarcoma as initial presentation of therapy-related myeloid neoplasms: a single institution experience. Int J Hematol 100: 457-463, 2014. [DOI] [PubMed] [Google Scholar]
- 2. Vardiman JW, Arber DA, Brunning RD, et al. Therapy-related myeloid neoplasms. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Swerdlow SH, Campo E, Harris NL, et al. , Eds. IARC Press, Lyon, 2017: 153-155. [Google Scholar]